About Wake Forest University
Wake Forest University is a private research university in Winston-Salem, North Carolina. Founded in 1834, the university received its name from its original location in Wake Forest, north of Raleigh, North Carolina.
Clinical Trials at Wake Forest University
During the past decade, Wake Forest University conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 40 clinical trials were completed, i.e. on
average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 20 clinical trials were completed. i.e. 51.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Wake Forest University" #1 sponsor was "Wake Forest University" with 10 trials, followed by "Wake Forest University Health Sciences" with 10 trials
sponsored, "Johns Hopkins University" with 5 trials sponsored, "Massachusetts General Hospital" with 4 trials sponsored and "National Cancer Institute (NCI)"
with 4 trials sponsored. Other sponsors include 150 different institutions and
companies that sponsored additional 126 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Wake Forest University"
#1 collaborator was "Wake Forest University" with 16 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 12 trials as a collaborator, "National Institute on Aging (NIA)" with 12 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 7 trials as a collaborator and "Wake Forest University Health Sciences" with 7 trials as a collaborator. Other collaborators include 287 different institutions and companies that were
collaborators in the rest 179 trials.
Clinical Trials Conditions at Wake Forest University
According to Clinical.Site data, the most researched conditions in "Wake Forest University" are
"Amyotrophic Lateral Sclerosis" (7 trials), "Covid19" (5 trials), "Aging" (4 trials), "Atherosclerosis" (4 trials) and "Heart Failure" (4 trials). Many other conditions were trialed in "Wake Forest University" in a lesser frequency.
Clinical Trials Intervention Types at Wake Forest University
Most popular intervention types in "Wake Forest University" are "Drug" (90 trials), "Other" (34 trials), "Device" (22 trials), "Procedure" (20 trials) and "Behavioral" (16 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (33 trials), "Vehicle" (4 trials), "Lenalidomide" (3 trials), "pharmacological study" (3 trials) and "placebo" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Wake Forest University
The vast majority of trials in "Wake Forest University" are
179 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Wake Forest University
Currently, there are NaN active trials in "Wake Forest University".
undefined are not yet recruiting,
28 are recruiting,
20 are Active, not recruiting,
and 6 are Enrolling by invitation.
In total, there were 109 completed trials in Wake Forest University,
undefined suspended trials,
and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Wake Forest University, 14 "Phase 1"
clinical trials were conducted, 41 "Phase 2" clinical
trials and 48 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 8 trials, and there were
also 46 trials that are defined as “Not Applicable".